The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

INKT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.81%

Insider Buying (Last 12 Months): $663,552.92

Insider Selling (Last 12 Months): $95,000.00

MiNK Therapeutics Insider Trading History Chart

MiNK Therapeutics Share Price & Price History

^$0.87

▼ -0.04 (-4.39%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MiNK Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/16/2023	Agenus Inc	Major Shareholder	Buy	429	$1.10	$471.90	21,772,863
10/12/2023	Agenus Inc	Major Shareholder	Buy	3,173	$1.10	$3,490.30	21,753,061
10/4/2023	Agenus Inc	Major Shareholder	Buy	15,001	$1.09	$16,351.09	21,749,888
8/28/2023	Agenus Inc	Major Shareholder	Buy	12,808	$1.45	$18,571.60	21,705,209
8/24/2023	Agenus Inc	Major Shareholder	Buy	170,244	$1.54	$262,175.76	21,692,401
5/10/2023	Agenus Inc	Major Shareholder	Buy	22,065	$1.51	$33,318.15	21,617,112
5/5/2023	Agenus Inc	Major Shareholder	Buy	100,200	$0.95	$95,190.00	21,595,047
5/5/2023	Garo H Armen	Director	Sell	100,000	$0.95	$95,000.00	1,866,400
5/3/2023	Agenus Inc	Major Shareholder	Buy	128,689	$1.08	$138,984.12	21,473,374
5/2/2023	Garo H Armen	Director	Buy	100,000	$0.95	$95,000.00	1,978,010
7/18/2022	Ulf Wiinberg	Director	Buy	3,339	$1.33	$4,440.87	281,639

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for MiNK Therapeutics (NASDAQ:INKT)

2.87% of MiNK Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

MiNK Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Citadel Advisors LLC	42,141	$45K	0.0%	N/A	0.122%
11/14/2023	Oracle Investment Management Inc.	36,898	$41K	0.0%	-26.9%	0.107%
8/15/2023	Wells Fargo & Company MN	27,423	$58K	0.0%	+83,000.0%	0.079%
8/15/2023	Goldman Sachs Group Inc.	17,014	$36K	0.0%	N/A	0.049%
8/15/2023	Captrust Financial Advisors	39,542	$83K	0.0%	N/A	0.115%
8/15/2023	Citadel Advisors LLC	51,048	$0.11M	0.0%	N/A	0.148%
8/14/2023	Oracle Investment Management Inc.	50,461	$0.11M	0.1%	N/A	0.146%
8/14/2023	State Street Corp	28,773	$60K	0.0%	+159.0%	0.083%
8/14/2023	Deep Track Capital LP	324,867	$0.68M	0.0%	N/A	0.941%
8/11/2023	Renaissance Technologies LLC	145,528	$0.31M	0.0%	+1,312.9%	0.423%
8/11/2023	BlackRock Inc.	82,029	$0.17M	0.0%	+655.6%	0.238%
8/11/2023	Geode Capital Management LLC	92,723	$0.20M	0.0%	+266.6%	0.269%
8/11/2023	Artal Group S.A.	228,216	$0.48M	0.0%	-21.2%	0.663%
7/27/2023	Virtu Financial LLC	14,232	$30K	0.0%	N/A	0.041%
5/12/2023	First Republic Investment Management Inc.	32,400	$61K	0.0%	-38.3%	0.094%
2/15/2023	Millennium Management LLC	10,877	$28K	0.0%	N/A	0.032%
2/13/2023	First Republic Investment Management Inc.	52,500	$0.14M	0.0%	-35.6%	0.155%
2/13/2023	Longbow Finance SA	166,666	$0.44M	0.1%	N/A	0.493%
2/10/2023	StoneX Group Inc.	17,821	$47K	0.0%	N/A	0.053%
11/15/2022	Vanguard Group Inc.	49,107	$0.10M	0.0%	N/A	0.145%
11/4/2022	First Republic Investment Management Inc.	81,500	$0.17M	0.0%	N/A	0.243%
5/13/2022	Renaissance Technologies LLC	25,760	$58K	0.0%	-26.6%	0.077%
2/15/2022	Sofinnova Investments Inc.	345,499	$1.54M	0.1%	N/A	1.031%

Data available starting January 2016

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.

Today's Range

Now: $0.87

$0.87

$0.96

50 Day Range

MA: $0.96

$0.86

$1.56

52 Week Range

Now: $0.87

$0.75

$3.34

Volume

42,419 shs

Average Volume

91,714 shs

Market Capitalization

$30.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of MiNK Therapeutics?: MiNK Therapeutics' top insider shareholders include:
Agenus Inc (Major Shareholder)
Garo H Armen (Director)
Ulf Wiinberg (Director)
Learn More about top insider investors at MiNK Therapeutics.